References
1a
Ezaki M.
Iwami M.
Yamashita M.
Hashimoto S.
Komori T.
Umehara K.
Mine Y.
Kohsaka M.
Aoiki H.
Imanaka H.
J. Antibiot.
1985,
38:
1453
1b
Uchida I.
Shigematsu N.
Ezaki M.
Hashimoto M.
J. Antibiot.
1985,
38:
1462
1c
Uchida I.
Ezaki M.
Shigematsu N.
Hashimoto M.
J. Org. Chem.
1985,
50:
1341
1d
Kannan R.
Williams DH.
J. Org. Chem.
1987,
52:
5435
1e
Hempel JC.
Brown FK.
J.
Am. Chem. Soc.
1989,
111:
7323
1f
Brown FK.
Hempel JC.
Dixon JS.
Amato S.
Mueller L.
Jeffs PW.
J.
Am. Chem. Soc.
1989,
111:
7328
2a
Pruess DL.
Kellett M.
J.
Antibiot.
1983,
36:
208
2b
Evans RH.
Ax H.
Jacoby A.
Williams TH.
Jenkis E.
Scannell JP.
J.
Antibiot.
1983,
36:
213
2c
Müller J.-C.
Toome V.
Pruess DL.
Blount JF.
Weigele M.
J. Antibiot.
1983,
36:
217
3a
Koiso Y.
Natori M.
Iwasaki S.
Sato S.
Sonoda R.
Fujita Y.
Yaegashi H.
Sato Z.
Tetrahedron Lett.
1992,
33:
4157
3b
Koiso Y.
Morisaki N.
Yamashita Y.
Mitsui Y.
Shirai R.
Hashimoto Y.
Iwasaki S.
J.
Antibiot.
1998,
51:
418
3c
Koiso Y.
Li Y.
Iwasaki S.
Hanaoka K.
Kobayashi T.
Sonoda R.
Fujita Y.
Yaegashi H.
Sato Z.
J. Antibiot.
1994,
47:
765
3d
Morisaki N.
Mitsui Y.
Yamashita Y.
Koiso Y.
Shirai R.
Hashimoto Y.
Iwasaki S.
J. Antibiot.
1998,
51:
423
4a
Talbot G.
Gaudry R.
Berlinguet L.
Can. J. Chem.
1956,
34:
911
4b
Mizusaki K.
Makisumi S.
Bull. Chem. Soc. Jpn.
1981,
54:
470
4c
Hausler J.
Liebigs
Ann. Chem.
1992,
1231
4d
Jacob M.
Roumestant ML.
Viallefont P.
Martinez J.
Synlett
1997,
691
5a
De Bernardo S.
Tengi JP.
Sasso GJ.
Weigele M.
J.
Org. Chem.
1985,
50:
3457
5b
Girard A.
Greck C.
Genêt JP.
Tetrahedron
Lett.
1998,
39:
4259
5c
Mues H.
Kazmaier U.
Synthesis
2001,
487
6
Schmidt U.
Meyer R.
Leitenberger V.
Stäbler F.
Lieberknecht A.
Synthesis
1991,
409
7
Jackson RFW.
Rettie AB.
Wood A.
Wythes MJ.
J. Chem.
Soc., Perkin Trans. 1
1994,
1719
8
Rudolph J.
Hannig F.
Theis H.
Wischnat R.
Org. Lett.
2001,
3:
3153
9
Hutton CA.
White JM.
Tetrahedron Lett.
1997,
38:
1643
10
Corey EJ.
Xu F.
Noe MC.
J.
Am. Chem. Soc.
1997,
119:
12414
11
Lygo B.
Wainwright PG.
Tetrahedron Lett.
1997,
38:
8595
12a
Ooi T.
Kameda M.
Maruoka K.
J. Am. Chem. Soc.
1999,
121:
6519
12b
Ooi T.
Takeuchi M.
Kameda M.
Maruoka K.
J. Am. Chem. Soc.
2000,
122:
5228
12c
Kita T.
Georgieva A.
Hashimoto Y.
Nakata T.
Nagasawa K.
Angew.
Chem. Int. Ed.
2002,
41:
2832
13
O’Donnell MJ.
Aldrichimica Acta
2001,
34:
3
14a
Lygo B.
Crosby J.
Peterson JA.
Tetrahedron Lett.
1999,
40:
1385
14b
Lygo B.
Tetrahedron
Lett.
1999,
40:
1389
15
Boisnard S.
Carbonnelle A.-C.
Zhu J.
Org.
Lett.
2001,
3:
2061
16
Carbonnelle A.-C.
Zhu J.
Org. Lett.
2000,
2:
3477
17 Substrate-directed transformation,
see: Hoveyda AH.
Evans DA.
Fu GC.
Chem.
Rev.
1993,
93:
1307
Double asymmetric induction:
18a
Horeau A.
Kagan HB.
Vigneron JP.
Bull. Soc. Chim. Fr.
1968,
3795
18b
Masamune S.
Choy W.
Petersen JS.
Sita LR.
Angew. Chem., Int. Ed.
Engl.
1985,
24:
1
19 We thank one of the reviews for pointing
out this control experiment. This result was not unexpected, but
it didn’t allow us to conclude whether the observed stereoselectivity in
the presence of chiral ammonium salt was intrinsic to our substrate
or was the consequence of the lack of the catalyst assistance.
20
Estiarte MA.
Diez A.
Rubiralta M.
Jackson RFW.
Tetrahedron
2001,
57:
157
21 Compound 17.
Rf = 0.5 (eluent: ethyl acetate/heptane = 1/4); IR
(CHCl3) 3444, 3024, 2982, 1712, 1507 cm-1; 1H
NMR (300 MHz, CDCl3, 293 K) δ 1.44 (s, 9 H)
Hz, 1.46 (s, 9 H), 1.65-1.82 (m, 1 H), 1.93-1.98
(m, 1 H), 3.08-3.17 (ddd, 1 H, J
1 = 13.3
Hz, J
2 = 7.8 Hz, J
3 = 6 Hz), 3.36-3.42
(m, 1 H), 3.91 (m, 1 H), 4.22 (m, 1 H), 5.10 (s, 2 H), 5.26 (m,1
H), 5,39 (m, 1 H), 7,35 (m, 5 H); 13C
NMR (75 MHz, CDCl3) δ 28.0, 28.3, 38.0, 46.8,
52.1, 66.9, 69.1, 82.3, 82.5, 128.1, 128.2, 128.5, 136.4, 156, 157.1,
171.6; MS (ESI) m/z 461 (M + Na); [α]D = +9.3
(c 0.9 CHCl3). Compound 18. Rf = 0.41 (eluant: ethyl
acetate/heptane = 1/1); IR (CHCl3)
3445, 1783, 1717 cm-1; 1H
NMR (300 MHz, CDCl3, 293 K) δ 1.45 (s, 1 H), 2.32
(m, 1 H), 2.46-2.53 (m, 1 H), 3.30 (dt, 1 H, J
1
= 15
Hz, J
2 = 6.3 Hz),
3.52-3.56 (m, 1 H), 4.23 (br d, 1 H, J = 6.8
Hz), 4.75 (br s, 1 H), 5.12-5.18 (m, 4 H), 7.36 (m, 5 H); 13C
NMR (75 MHz, CDCl3) δ 28.2, 31.4, 44.6, 49.5,
67.1, 77.2, 80.7, 128.1, 128.2, 128.6, 136.2, 155.3, 156.7, 175.1;
MS (EI)
m/z 387 (M + Na),
403 (M + K); [α]D = -18.1
(c 0.57 CHCl3); [α]D = -22.4
(c 0.5 CHCl3).
[20]
Double stereoselection using matched
and mismatched chiral ammonium catalyst in the alkylation of a Gly-l-Phe derivative has been documented very
recently, see:
22a
Ooi T.
Tayama E.
Maruoka K.
Angew.
Chem. Int. Ed.
2003,
42:
579
22b For an earlier example
of an achiral quarternary ammonium salt catalyzed alkylation of
a dipeptide, see: O’Donnell MJ.
Zhou C.
Scott WL.
J.
Am. Chem. Soc.
1996,
118:
6070
23a
Morikawa K.
Sharpless KB.
Tetrahedron
Lett.
1993,
34:
5575
23b
Guzman-Perez A.
Corey EJ.
Tetrahedron Lett.
1997,
34:
5941